MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Journal of Thoracic Oncology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,243 results · 1 filter active ·
Results by year
20062025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,243 works in the cohort · of 4,299,418page 2 of 25

Labels cover 7 of 1,243 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,243 of 1,243 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non–Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153)
David R. Spigel, Michael McCleod, Robert M. Jotte, Lawrence H. Einhorn, Leora Horn, David Waterhouse +15 more
2019· article· en· Journal of Thoracic Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
187
citations
affno abstractunlabeled
New Approaches to SCLC Therapy: From the Laboratory to the Clinic
John T. Poirier, Julie George, Taofeek K. Owonikoko, Anton Berns, Élisabeth Brambilla, Lauren A. Byers +39 more
2020· review· en· Journal of Thoracic Oncology· Medicine
distilled prediction:candidate · research_integrityconsensus · none
176
citations
fundno affno abstractunlabeled
Crizotinib in Patients With MET-Amplified NSCLC
D. Ross Camidge, Gregory A. Otterson, Jeffrey W. Clark, Sai‐Hong Ignatius Ou, Jared Weiss, Steven Ades +8 more
2021· article· en· Journal of Thoracic Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
168
citations
affunlabeled
Tobacco Smoking and Risk of Second Primary Lung Cancer
Jacqueline V. Aredo, Sophia J. Luo, Rebecca M. Gardner, Nilotpal Sanyal, Eunji Choi, Thomas Hickey +18 more
2021· review· en· Journal of Thoracic Oncology· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
131
citations
afffundno abstractunlabeled
Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines
Simron Singh, Emily K. Bergsland, Cynthia Card, Thomas A. Hope, Pamela L. Kunz, David Laidley +16 more
2020· review· en· Journal of Thoracic Oncology· Medicine
distilled prediction:candidate · metaepi_narrow+stsconsensus · none
116
citations

How this was built: Screen · Findings · About